Skip to Main Content

Author Details

Mitchell Kamrava
Cedars Sinai Medical Center
2005
152
25
PMIDPaper TitleJournal TitlePublished Year
36191741GEC-ESTRO (ACROP)-ABS-CBG Consensus Brachytherapy Target Definition Guidelines for Recurrent Endometrial and Cervical Tumors in the Vagina.Int J Radiat Oncol Biol Phys2023
37508411Demographic Factors Predict Risk of Lymph Node Involvement in Patients with Endometrial Adenocarcinoma.Biology (Basel)2023
37193616Brachytherapy training in India: Results from the GEC-ESTRO-India survey.Brachytherapy2023
37059334Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study.Radiother Oncol2023
370243503D printing in brachytherapy: A systematic review of gynecological applications.Brachytherapy2023
36997449A Single-Institution Retrospective Study of Three-Fraction HDR Accelerated Partial Breast Irradiation.Brachytherapy2023
36725200Embracing a future of progress in gynecologic brachytherapy.Brachytherapy2023
36437221A "scoping" review of prostate brachytherapy and immune responses.Brachytherapy2023
36436615Left Anterior Descending Coronary Artery Radiation Dose Association With All-Cause Mortality in NRG Oncology Trial RTOG 0617.Int J Radiat Oncol Biol Phys2023
34732290American Brachytherapy Society radiation oncology alternative payment model task force: Quality measures and metrics for brachytherapy.Brachytherapy2022
35675851A Comparison of Patient- and Clinician-Reported Acute Toxic Effects During Radiation Therapy for Primary Breast Cancer.Int J Radiat Oncol Biol Phys2022
35512991In Regard to Apisarnthanarax et al.Pract Radiat Oncol2022
36478697Single-fraction high-dose-rate brachytherapy: a scoping review on outcomes and toxicities for all disease sites.J Contemp Brachytherapy2022
36328092Brachytherapy training survey among radiation oncology residents in Europe.Radiother Oncol2022
36117086Partial breast irradiation: An updated consensus statement from the American brachytherapy society.Brachytherapy2022
35317320Chemotherapy predictors and a time-dependent chemotherapy effect in metastatic esophageal cancer.World J Gastrointest Oncol2022
35249823Evaluation of burnout in physician members of the American Brachytherapy Society.Brachytherapy2022
35311991Quantitative Nodal Burden and Mortality Across Solid Cancers.J Natl Cancer Inst2022
35216809Pathologic primary tumor factors associated with risk of lymph node involvement in patients with non-endometrioid endometrial cancer.Gynecol Oncol2022
34911701Evaluation of patterns of progression on poly (ADP-ribose) polymerase inhibitor (PARPi) maintenance in ovarian cancer: a cross-sectional study.Int J Gynecol Cancer2022
34930712Driving accountable care with brachytherapy.Brachytherapy2022
34895839Evaluation of sociodemographic and baseline patient characteristic differences in cervical cancer patients treated with either external beam or brachytherapy boost.Brachytherapy2022
32811762Interstitial high-dose-rate brachytherapy in the treatment of keloids: Moving toward a volumetric approach.Brachytherapy2021
33908045Prediction of soft tissue sarcoma response to radiotherapy using longitudinal diffusion MRI and a deep neural network with generative adversarial network-based data augmentation.Med Phys2021
33789823Interstitial brachytherapy for gynecologic malignancies: Complications, toxicities, and management.Brachytherapy2021
33818620Red Blood Cell Transfusion Practices for Patients With Cervical Cancer Undergoing Radiotherapy.JAMA Netw Open2021
33818052Integrating PARP Inhibitors Into Advanced Prostate Cancer Therapeutics.Oncology (Williston Park)2021
34889947A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer.JAMA Netw Open2021
35079662Ovarian Transposition Before Pelvic Radiation Therapy: Spatial Distribution and Dose Volume Analysis.Adv Radiat Oncol2021
34588143ACR-ABS-ASTRO practice parameter for the performance of radionuclide-based high-dose-rate brachytherapy.Brachytherapy2021
34550749Socioeconomic and Racial Determinants of Brachytherapy Utilization for Cervical Cancer: Concerns for Widening Disparities.JCO Oncol Pract2021
34484350High-dose-rate fractionated brachytherapy monotherapy for localized prostate cancer: a systematic review and meta-analysis.J Contemp Brachytherapy2021
34303600American Brachytherapy Society (ABS) consensus statement for soft-tissue sarcoma brachytherapy.Brachytherapy2021
34044264Hypofractionated radiation therapy and wound healing after massive sarcoma resection: Case report and review of the literature.Int J Surg Case Rep2021
34098977Outcomes with multi-disciplinary management of central lung tumors with CT-guided percutaneous high dose rate brachyablation.Radiat Oncol2021
34049784Outcomes with brachytherapy based dose escalation for gleason 8 versus 9-10 prostate cancer: An NCDB analysis.Urol Oncol2021
33974058Paid Parental Leave Policies Among U.S. News & World Report 2020-2021 Best Hospitals and Best Hospitals for Cancer.JAMA Netw Open2021
34081738Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer.PLoS One2021
33073061Evaluation of Mobile Health Applications to Track Patient-Reported Outcomes for Oncology Patients: A Systematic Review.Adv Radiat Oncol2021
32423787Proposed brachytherapy recommendations (practical implementation, indications, and dose fractionation) during COVID-19 pandemic.Brachytherapy2020
31964600A dosimetric evaluation of a single urethral constraint for high-dose-rate prostate brachytherapy.Brachytherapy2020
32054730A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma.Clin Cancer Res2020
32049953Durable Response to Carboplatin, Etoposide, Nivolumab, and Ipilimumab in Metastatic High-Grade Neuroendocrine Carcinoma of the Gallbladder.Pancreas2020
31688338Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors.J Glaucoma2020
32014146SAbR as an Alternative Boost Modality for Cervical Cancer: A Cautionary Exercise.Int J Radiat Oncol Biol Phys2020
31917178American Brachytherapy Society working group report on the patterns of care and a literature review of reirradiation for gynecologic cancers.Brachytherapy2020
33282470A radiopaque polymer hydrogel as an irreversible electroporation compatible fiducial marker for pancreas stereotactic body radiotherapy.J Radiosurg SBRT2020
33024512Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy.World J Gastrointest Surg2020
33305096Clinical Development and Evaluation of Megavoltage Topogram for Fast Patient Alignment on Helical Tomotherapy.Adv Radiat Oncol2020
33069345Radiation for Cancers of the Uterine Corpus and Cervix: Incremental Steps, and Glimmers of the Future.Int J Radiat Oncol Biol Phys2020
  • 1 - 50 of 152

Recommended Authors

University of California los angeles
Career Start Year 2016
Number of shared co-authors 26
Stanford University
Career Start Year 2014
Number of shared co-authors 16
The University of Sydney, Westmead Hospital
Career Start Year 2014
Number of shared co-authors 3
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 9
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Career Start Year 2012
Number of shared co-authors 25
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 4
University of Washington
Career Start Year 2010
Number of shared co-authors 21
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 4
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 1
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 14
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 2006
Number of shared co-authors 16
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 13
Ascension Providence Hospital
Career Start Year 2005
Number of shared co-authors 15
New York-Presbyterian Hospital, Weill Cornell Medical Center
Career Start Year 2005
Number of shared co-authors 7
University of Toronto, Princess Margaret Cancer Centre
Career Start Year 2004
Number of shared co-authors 17
University of Texas Southwestern Medical Center
Career Start Year 2004
Number of shared co-authors 9
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 16
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 15
University of Chicago
Career Start Year 1997
Number of shared co-authors 16
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Career Start Year 1996
Number of shared co-authors 1
Princess Margaret Hospital, University of Toronto
Career Start Year 1995
Number of shared co-authors 16
Cleveland Clinic
Career Start Year 1995
Number of shared co-authors 17
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 2
Huntsman Cancer Institute, University of Utah
Career Start Year 1994
Number of shared co-authors 14
Clinica Universitaria de Navarra
Career Start Year 1993
Number of shared co-authors 11
Duke University School of Medicine
Career Start Year 1993
Number of shared co-authors 17
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 21
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1990
Number of shared co-authors 2
Mayo Clinic
Career Start Year 1989
Number of shared co-authors 5
Sutter Cancer Centers Radiation Oncology Services
Career Start Year 1987
Number of shared co-authors 18

Collaborators

University of California los angeles
Co-authored papers 38
University of California los angeles
Co-authored papers 32
university of california los angeles Medical Center
Co-authored papers 16
University of California los angeles
Co-authored papers 11
University of California los angeles
Co-authored papers 10
Stanford University
Co-authored papers 9
Weill Cornell Medical College
Co-authored papers 8
University of California los angeles
Co-authored papers 8
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Co-authored papers 7
University of California Los Angeles
Co-authored papers 6
University of California Los Angeles
Co-authored papers 6
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 6
Ruijin Hospital
Co-authored papers 5
University of California-Los Angeles
Co-authored papers 5
Stanford Cancer Institute, Stanford School of Medicine
Co-authored papers 5
National Cancer Institute
Co-authored papers 4
Cedars-Sinai Medical Center
Co-authored papers 4
University of California, Los Angeles David Geffen School of Medicine
Co-authored papers 4
University of Pennsylvania
Co-authored papers 4
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers 4
University of California los angeles
Co-authored papers 4
University of California-Los Angeles
Co-authored papers 4
University of California
Co-authored papers 4
David Geffen School of Medicine at university of california los angeles
Co-authored papers 3
University of California-Los Angeles
Co-authored papers 3
Centre Hospitalier Universitaire de Quebec
Co-authored papers 3
Jonsson Comprehensive Cancer Center, University of California Los Angeles
Co-authored papers 3
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 3
David Geffen School of Medicine at University of California Los Angeles
Co-authored papers 3
University of California-Los Angeles
Co-authored papers 3